AU Patent

AU2015200637C1 — Tablets for combination therapy

Assigned to Gilead Sciences Inc · Expires 2017-08-03 · 9y expired

What this patent protects

Abstract: The invention provides solid dose forms (e.g. tablets) comprising a compound of Formula I, a compound of Formula II, a compound of Formula III and a salt of Formula IV. HO CHs CO Ph 1 o' poh/ So P-a H02C F NO H 1a 0 0O 0

USPTO Abstract

Abstract: The invention provides solid dose forms (e.g. tablets) comprising a compound of Formula I, a compound of Formula II, a compound of Formula III and a salt of Formula IV. HO CHs CO Ph 1 o' poh/ So P-a H02C F NO H 1a 0 0O 0

Drugs covered by this patent

Patent Metadata

Patent number
AU2015200637C1
Jurisdiction
AU
Classification
—
Expires
2017-08-03
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.